The European Hematology Association (EHA) welcomes the proposed targeted revision of the In Vitro Diagnostic Medical Devices Regulation (IVDR) and supports measures to improve regulatory proportionality, reduce unnecessary bureaucracy, and safeguard patient access to essential diagnostics while maintaining high standards of safety and performance.
EHA
European Hematology Association (EHA)
NGO · Netherlands · EU Transparency Register 91666778136-14
8
positions filed
in the 665 files tracked
5
legislative files
of 665 tracked
6
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 410 trade unions and professional associations on this site, they rank #115 by legislative files engaged, a count of participation, not a measure of influence.
4.8
declared lobbying FTE
self-declared
€600K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2012
in the register since
Declares membership of
- BioMed Alliance →
- European Cancer Organisation (ECO)
- European Alliance for Personalised Medicine (EAPM)
- Rare Cancers Europe (hosted by ESMO: https://www.esmo.org/policy/rare-cancers-working-group/about-rare-cancers-workin…
- European Network for TYA with Cancer (ENTYAC), hosted by SIOP Europe: https://siope.eu/news/discover-ENTYAC-Oct22/
- Coalition for Reducing Bureaucracy in Clinical Trials, hosted by EHA: https://bureaucracyincts.eu/
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026).
- Register category
- Trade unions and professional associations
- Registered as
- European Hematology Association (EHA)
- Head office
- The Hague, Netherlands
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track European in PolicySpeak: request access →
Work at European Hematology Association (EHA)? so we know who speaks for it.
Their record over time
European Hematology Association (EHA) filed 8 positions between 27 Apr 2021 and 31 Jul 2026, across 5 of the 665 legislative files tracked here, attaching a full position paper 6 times.
2021 · 1 filed2022 · 1 filed2023 · 2 filed2025 · 1 filed2026 · 3 filed
What they argued
The European Hematology Association (EHA) is the leading representative of hematology and hematology professionals in Europe. A not-for-profit, public-benefit organization with nearly 7,000 members, EHA supports career development and research, develops and harmonizes hematology education, and advocates for enhanced, affordable and equitable access to innovative therapies for patients with hematological disease…
The European Hematology Association (EHA) is the leading representative of hematology and hematology professionals in Europe. A not-for-profit, public-benefit organization with nearly 7,000 members, EHA supports career development and research, develops and harmonizes hematology education, and advocates for enhanced, affordable and equitable access to innovative therapies for patients with hematological disease…
Hematology is at the forefront of medical and technological advances which have brought truly patient-centered, personalized medicine within reach. Clinicians, researchers, policymakers and regulators at the EU and national level, research funders and the pharmaceutical industry have a shared responsibility to ensure that innovative treatments are affordable and available for all patients in Europe.
The European Hematology Association (EHA) is the leading representative of hematology and hematology professionals in Europe. We are a not-for-profit organization with over 12,000 members. EHA develops and harmonises hematology education, produces clinical practice guidelines, supports career development and research, and advocates for affordable and equitable access to innovative therapies for patients with…
The European Hematology Association (EHA) is the leading organization representing hematology professionals in Europe. As a not-for-profit, public-benefit association with over 10,000 members and an annual congress attracting around 18,000 stakeholders, EHA supports career development, research, harmonized education, and advocates for equitable access to innovative therapies for patients with hematological diseases…
The European Hematology Association (EHA) warmly welcomes the legislative proposal for an EU SoHO Regulation which represents a big step forward for protecting patient and donor safety, improving access to SoHOs and innovative SoHO-derived therapies, ensuring sustainability of supply, facilitating innovation, and for increasing efficiency and coherence of regulation and oversight.
About EHA: The European Hematology Association (EHA) is the leading representative of hematology and hematology professionals in Europe. We are a notforprofit, public benefit organization with over 11,000 members.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put European Hematology Association (EHA) next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Showing 5 of 118.
Is this your organization?
Everything on this page comes from European Hematology Association (EHA)’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.